Tag: Bluebird Bio acquisition

bluebird-bio-sells-tself-to-private-equity-amid-challenges

Bluebird Bio Sells Itself to Private Equity Amid Challenges

Bluebird Bio: A Story of Innovation, Struggles, and a New BeginningAfter years of pioneering gene therapies and promising groundbreaking treatments, Bluebird Bio has announced its sale to private equity firms Carlyle and SK Capital...

BREAKING NEWS